sample

Posted on September 9, 2025September 9, 2025 by govindaharale123@gmail.com

Sample Event

Posted on August 27, 2025August 27, 2025 by govindaharale123@gmail.com

2nd Annual EVIDENCE 360: RWE, Pricing & Reimbursement Summit

London, UK
16–17 March 2026

Days

Hours

Minutes

Seconds

This two-day event is designed as a dedicated platform for stakeholders across the UK and European healthcare ecosystem to explore the evolving role of Real-World Evidence (RWE) in shaping market access, pricing, and reimbursement strategies.

With increasing pressure to deliver cost-effective, evidence-based care, this summit brings together thought leaders from across pharma, biotech, regulators, payers, HTA bodies, and digital health to address the region’s most pressing access and pricing challenges.

Attendees

0 +

Speakers

0 +

Countries Represented

0 +

Senior Decision Makers

0 +

Who Should Attend

Research & Development (R&D):

Preclinical Research
Translational Research
Biomarker Discovery
Target Identification & Validation

Clinical Development:

Clinical Operations
Medical Affairs
Clinical Pharmacology
Early/Translational Clinical Programs

Translational Medicine:

Clinical Biomarker Teams
Genomics/Proteomics Analysis
Companion Diagnostics Development

Regulatory Affairs:

Regulatory Science
Companion Diagnostic Submissions
Health Authority Engagement

Who Should Attend

Pharma, Biotech & Industry Professionals in

Real World Evidence

Market Access

Value Access

HEOR

Pricing & Reimbursement

Epidemiology

HTA

Patient Advocacy

Regulatory

Payers/Policy

Digital Health

Data Platforms

Consulting

Investors

Others

Final Decision Makers

Chief Executive Officer

Chief Scientific Officer

Chief Medical Officer

Vice President

Executive Director

Director

Manager

Sr. Manger

Key Department

Research & Development (R&D):

Preclinical Research
Translational Research
Biomarker Discovery
Target Identification & Validation

Clinical Development:

Clinical Operations
Medical Affairs
Clinical Pharmacology
Early/Translational Clinical Programs

Translational Medicine:

Clinical Biomarker Teams
Genomics/Proteomics Analysis
Companion Diagnostics Development

Regulatory Affairs:

Regulatory Science
Companion Diagnostic Submissions
Health Authority Engagement

Final Decision Makers

Connect With The Entire Regional Ecosystem
Under One Roof

Industry Stakeholders

Chief Executive Officer

Final Decision Makers

Chief Executive Officer

Chief Scientific Officer

Director

Chief Medical Officer

Sr. Manger

Vice President

Manager

Executive Director

2025 Dubai Edition Speakers

From Real-World Evidence Leaders to
Market Access Pioneers

Join an exceptional lineup of senior executives, policy experts, and thought leaders driving the future of healthcare. The 2026 edition will bring together influential voices from pharmaceutical and biotech companies, payers, HTA bodies, regulators, and solution providers—covering the full spectrum of real-world evidence, pricing, reimbursement, and market access.

LISTING PARTNERS

View The Glimpses Of Our Past Edition

EVIDENCE 360 Summit 2025 – Frankfurt

The inaugural EVIDENCE 360 Summit took place on 26–27 May 2025 in Frankfurt, Germany, bringing together leaders from across the pharmaceutical, biotech, payer, and regulatory communities.

Over two dynamic days, the summit hosted insightful discussions, case studies, and panel debates on the evolving role of real-world evidence in shaping pricing, reimbursement, and market access strategies.

The Frankfurt edition established the EVIDENCE 360 Summit as a leading platform for advancing RWE strategies, offering unparalleled opportunities to exchange ideas, build collaborations, and explore solutions that will define the future of healthcare access.

Connecting with Capital

Elite Investor Ecosystem at HODL

Crypto VCs

Engage with leading venture capital firms specializing in blockchain and DeFi, seeking promising projects across various development stages.

Angel Investors

Engage with leading venture capital firms specializing in blockchain and DeFi, seeking promising projects across various development stages.

Web3 Fund Managers

Engage with leading venture capital firms specializing in blockchain and DeFi, seeking promising projects across various development stages.

Family Offices

Engage with leading venture capital firms specializing in blockchain and DeFi, seeking promising projects across various development stages.

Blockchain After Dark

The HODL
After-party

Where deals are sealed, connections flourish, and the future of Web3 unfolds
in an electrifying atmosphere of innovation and celebration.

Sponsor the Blockchain After Dark Experience

Elevate your brand where crypto’s most influential minds connect beyond the conference floor.

Exclusive brand visibility at crypto’s most anticipated networking event

MEDIA PARTNERS

LISTING PARTNERS

Investment Partners

Venue

London, UK

Contact Our Team Today

Where deals are sealed, connections flourish, and the future of Web3 unfolds
in an electrifying atmosphere of innovation and celebration.

For Speaking &
Partnerships

Nikita Patankar Parab

Founder, Managing Director

nikita@veridonglobal.com

For Sponsorship & Delegation

Prativa Sinha

Director

prativa@veridonglobal.com

2nd Annual EVIDENCE 360: RWE, Pricing & Reimbursement Summit

Posted on August 20, 2025September 14, 2025 by govindaharale123@gmail.com

Best Real World Evidence Conference In UK In 2025

2nd Annual EVIDENCE 360: RWE, Pricing & Reimbursement Summit

📍 London, UK
📅 16–17 March 2026

Days

Hours

Minutes

Seconds

Event Overview

Attendees

0 +

Speakers

0 +

Countries Represented

0 +

Senior Decision Makers

0 +

Where Data Drives Access & Decisions

Attendees

0 +

Senior Decision Makers

0 +

Speakers

0 +

Explore The Key Highlights

RWE for the UK & EU Region

Generating regionally compliant, high-quality evidence

Innovative Pricing & Reimbursement Model

Outcomes-based, managed entry, and adaptive approaches

Access
Harmonization

Addressing fragmentation in pricing and reimbursement across Europe

HTA
Evolution

Preparing for JCA, NICE’s Evidence Standards Framework, and evolving payer needs

Digital Health Integration

Leveraging EHRs, AI, and real-time registries for faster access

Who Should Attend

Research & Development (R&D):

Preclinical Research
Translational Research
Biomarker Discovery
Target Identification & Validation

Clinical Development:

Clinical Operations
Medical Affairs
Clinical Pharmacology
Early/Translational Clinical Programs

Translational Medicine:

Clinical Biomarker Teams
Genomics/Proteomics Analysis
Companion Diagnostics Development

Regulatory Affairs:

Regulatory Science
Companion Diagnostic Submissions
Health Authority Engagement

Who Should Attend

Pharma, Biotech & Industry Professionals in

Real World Evidence

Market Access

Value Access

HEOR

Pricing & Reimbursement

Epidemiology

HTA

Patient Advocacy

Regulatory

Payers/Policy

Digital Health

Data Platforms

Consulting

Investors

Others

Final Decision Makers

Chief Executive Officer

Chief Scientific Officer

President

Vice President

Executive Director

Assoicate/Senior Director

Manager/Sr. Manager

Head of Department

Key Department

Research & Development (R&D):

Preclinical Research
Translational Research
Biomarker Discovery
Target Identification & Validation

Clinical Development:

Clinical Operations
Medical Affairs
Clinical Pharmacology
Early/Translational Clinical Programs

Translational Medicine:

Clinical Biomarker Teams
Genomics/Proteomics Analysis
Companion Diagnostics Development

Regulatory Affairs:

Regulatory Science
Companion Diagnostic Submissions
Health Authority Engagement

Interactive Dashboard

PROCUREMENT BUDGET

Click a color

12% US $500,000 | US $1 million
29% US $100,000 | US $500,000
34% Less than US $100,000
25% More than US $1 million

SECTORS

Banks | Insurance | Micro-Finance | Policy Makers

BY JOB FUNCTION

IT & Security

Digital & Data Analytics

Fraud, Risk & Compliance

Operations & Strategy

Retail & Wholesale

Cards & Payments

Marketing & Loyalty

C-suite

VPs, Directors & Heads

Senior Managers

Why Attend

In-depth case studies on RWE applications in European and UK HTA submissions

Strategic discussions on region-specific pricing and reimbursement frameworks

Updates on EU HTA regulation, JCA implementation, and NICE RWE standards

Exploration of AI, digital endpoints, and patient-reported outcomes in evidence generation

Networking with European regulators, payers, and market access leaders

Final Decision Makers

Connect With The Entire Regional Ecosystem
Under One Roof

Industry Stakeholders

Chief Executive Officer

Final Decision Makers

Chief Executive Officer

Chief Scientific Officer

Director

Chief Medical Officer

Sr. Manger

Vice President

Manager

Executive Director

2026 UK Edition Speakers